- Home
- FBK vs ARWR Comparison
FBK vs ARWR Comparison
Compare FBK & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBK
- ARWR
- Stock Information
- Founded
- FBK 1906
- ARWR 2003
- Country
- FBK United States
- ARWR United States
- Employees
- FBK N/A
- ARWR N/A
- Industry
- FBK Major Banks
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- FBK Finance
- ARWR Health Care
- Exchange
- FBK Nasdaq
- ARWR Nasdaq
- Market Cap
- FBK 2.4B
- ARWR 2.6B
- IPO Year
- FBK 2016
- ARWR 1993
- Fundamental
- Price
- FBK $49.82
- ARWR $19.90
- Analyst Decision
- FBK Hold
- ARWR Buy
- Analyst Count
- FBK 5
- ARWR 11
- Target Price
- FBK $50.20
- ARWR $43.33
- AVG Volume (30 Days)
- FBK 133.3K
- ARWR 2.5M
- Earning Date
- FBK 04-14-2025
- ARWR 02-10-2025
- Dividend Yield
- FBK 1.52%
- ARWR N/A
- EPS Growth
- FBK N/A
- ARWR N/A
- EPS
- FBK 2.48
- ARWR N/A
- Revenue
- FBK $443,569,000.00
- ARWR $2,500,000.00
- Revenue This Year
- FBK N/A
- ARWR $3,336.78
- Revenue Next Year
- FBK $8.78
- ARWR $124.29
- P/E Ratio
- FBK $20.09
- ARWR N/A
- Revenue Growth
- FBK N/A
- ARWR N/A
- 52 Week Low
- FBK $33.35
- ARWR $17.05
- 52 Week High
- FBK $58.88
- ARWR $36.72
- Technical
- Relative Strength Index (RSI)
- FBK 37.20
- ARWR 49.40
- Support Level
- FBK $51.54
- ARWR $17.57
- Resistance Level
- FBK $52.99
- ARWR $21.84
- Average True Range (ATR)
- FBK 1.22
- ARWR 1.06
- MACD
- FBK -0.28
- ARWR 0.11
- Stochastic Oscillator
- FBK 4.34
- ARWR 54.57
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.